Number of Shares
73,200.00
Current Holdings Value*
$1.39 Mil
% of Portfolio
0.1%
Total Estimate Gain
$761,915.00
% of Total Estimate Gain
1.41%

Fidelity Advisor Biotechnology Fund's Merus NV Holding Summary

As of 2025-04-30, FIDELITY ADVISOR SERIES VII held 73,200.00 shares of Merus NV(MRUS), totaling $1.39 Mil. This investment constitutes 0.1% of their stock portfolio, and FIDELITY ADVISOR SERIES VII now holds 0.1% of the outstanding Merus NV(MRUS) stock.

The initial trade took place in 2024Q2. And since then Fidelity Advisor Biotechnology Fund has made 3 purchases of MRUS, at an average price of $47.38, for a total of 1.14 Mil shares. In addition, there have been 2 sales at an average price of $47.00 for 1.07 Mil shares. Based on historical transaction data and MRUS's current price of $63.26, Fidelity Advisor Biotechnology Fund's estimated gain on his MRUS holdings is $761,915.00, reflecting a 1.41% gain to date.

Fidelity Advisor Biotechnology Fund MRUS ($63.26) Holding Chart

Fidelity Advisor Biotechnology Fund MRUS ($63.26) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1